Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Espuelas, S. (Socorro) | |
| dc.creator | Legrand, P. (P.) | |
| dc.creator | Loiseau, P.M. (P.M.) | |
| dc.creator | Bories, C. (C.) | |
| dc.creator | Barratt, G. (G.) | |
| dc.creator | Irache, J.M. (Juan Manuel) | |
| dc.date.accessioned | 2011-10-24T15:13:12Z | - |
| dc.date.available | 2011-10-24T15:13:12Z | - |
| dc.date.issued | 2000 | - |
| dc.identifier.citation | Espuelas S, Legrand P, Loiseau PM, Bories C, Barratt G, Irache JM. In vitro reversion of amphotericin B resistance in leishmania donovani by poloxamer 188. Antimicrob Agents Chemother. 2000 Aug;44(8):2190-2. | es_ES |
| dc.identifier.issn | 0066-4804 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/19206 | - |
| dc.description.abstract | A micellar formulation of amphotericin B (AmB) solubilized with poloxamer 188 was evaluated against an AmB Leishmania donovani-resistant line. A concave isobologram showed a synergistic effect of this association against promastigotes. This result was confirmed with amastigotes since the 50% effective concentration of the new formulation was 100 times less than that of the control AmB formulation. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | American Society for Microbiology | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Leishmania donovani | es_ES |
| dc.subject | Poloxamer 188 | es_ES |
| dc.subject | Amphotericin B Resistance | es_ES |
| dc.title | In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188 | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | http://aac.asm.org/cgi/content/full/44/8/2190 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
